145 related articles for article (PubMed ID: 38304034)
1. Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer.
Monshaugen I; Luna L; Rhodes J; Kristiansen FIS; Lång A; Bøe SO; Dutta A; Su Z; Klungland A; Ougland R
Front Oncol; 2023; 13():1334112. PubMed ID: 38304034
[TBL] [Abstract][Full Text] [Related]
2. RNA m1A Methyltransferase TRMT6 Predicts Poorer Prognosis and Promotes Malignant Behavior in Glioma.
Wang B; Niu L; Wang Z; Zhao Z
Front Mol Biosci; 2021; 8():692130. PubMed ID: 34631793
[No Abstract] [Full Text] [Related]
3. Age-related noncanonical TRMT6-TRMT61A signaling impairs hematopoietic stem cells.
He H; Wang Y; Zhang X; Li X; Liu C; Yan D; Deng H; Sun W; Yi C; Wang J
Nat Aging; 2024 Feb; 4(2):213-230. PubMed ID: 38233630
[TBL] [Abstract][Full Text] [Related]
4. Research progress of N1-methyladenosine RNA modification in cancer.
Liu Y; Zhang S; Gao X; Ru Y; Gu X; Hu X
Cell Commun Signal; 2024 Jan; 22(1):79. PubMed ID: 38291517
[TBL] [Abstract][Full Text] [Related]
5. N
Li J; Zhang H; Wang H
Comput Struct Biotechnol J; 2022; 20():6578-6585. PubMed ID: 36467585
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome-wide 1-methyladenosine functional profiling of messenger RNA and long non-coding RNA in bladder cancer.
Yin JJ; Song YL; Guo YF; Dai YH; Chang Q; Wang T; Sun GQ; Lu P; Song DK; Zhang LR
Front Genet; 2024; 15():1333931. PubMed ID: 38482382
[No Abstract] [Full Text] [Related]
7. Identification of hepatoblastoma susceptibility loci in the TRMT6 gene from a seven-center case-control study.
Ma L; Zhu J; Zhang J; Zhang W; Li Y; Yang Z; Li S; Cheng J; Li L; He J; Liu P
J Cell Mol Med; 2024 Jan; 28(1):e18006. PubMed ID: 37850543
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
He YC; Bi YG; Jiang L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962
[TBL] [Abstract][Full Text] [Related]
9. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
11. Cooperative methylation of human tRNA3Lys at positions A58 and U54 drives the early and late steps of HIV-1 replication.
Fukuda H; Chujo T; Wei FY; Shi SL; Hirayama M; Kaitsuka T; Yamamoto T; Oshiumi H; Tomizawa K
Nucleic Acids Res; 2021 Nov; 49(20):11855-11867. PubMed ID: 34642752
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer.
Xie J; Ni J; Shi H; Wang K; Ma X; Li W; Peng B
Cancer Med; 2023 Mar; 12(5):5718-5735. PubMed ID: 36208024
[TBL] [Abstract][Full Text] [Related]
14. α-E-Catenin (CTNNA1) Inhibits Cell Proliferation, Invasion and EMT of Bladder Cancer.
Chi Q; Xu H; Song D; Wang Z; Wang Z; Ma G
Cancer Manag Res; 2020; 12():12747-12758. PubMed ID: 33364826
[TBL] [Abstract][Full Text] [Related]
15. N1-Methyladenosine (m1A) Regulation Associated With the Pathogenesis of Abdominal Aortic Aneurysm Through
Wu Y; Jiang D; Zhang H; Yin F; Guo P; Zhang X; Bian C; Chen C; Li S; Yin Y; Böckler D; Zhang J; Han Y
Front Cardiovasc Med; 2022; 9():883155. PubMed ID: 35620523
[TBL] [Abstract][Full Text] [Related]
16. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylated ITGA8 Facilitate Bladder Cancer Cell Proliferation and Metastasis.
Ma X; Zhang L; Liu L; Ruan D; Wang C
Appl Biochem Biotechnol; 2024 Jan; 196(1):245-260. PubMed ID: 37119505
[TBL] [Abstract][Full Text] [Related]
18. TRPM2-AS Promotes Bladder Cancer by Targeting miR-22-3p and Regulating GINS2 mRNA Expression.
Tian Y; Guan Y; Su Y; Yang T; Yu H
Onco Targets Ther; 2021; 14():1219-1237. PubMed ID: 33658791
[TBL] [Abstract][Full Text] [Related]
19. NUPR1 imparts oncogenic potential in bladder cancer.
Zhang L; Gao S; Shi X; Chen Y; Wei S; Mi Y; Zuo L; Qi C
Cancer Med; 2023 Mar; 12(6):7149-7163. PubMed ID: 36468653
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
